Phase 2 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to participate voluntarily, sign a consent form, follow the study rules, and attend follow-up appointments.
- You are able to provide enough tumor tissue samples (either recently collected or previously stored) for testing at a laboratory chosen by the study team.
- You have at least one tumor that can be measured using standard imaging guidelines.
- Your general health and ability to carry out daily activities meets a certain level (a score of 0 or 1 on a standard health scale — confirm with trial site).
- You are expected to live for at least 12 weeks.
- If you are a woman who could become pregnant, you must agree to use contraception from the time you sign the consent form until 7 months after your last dose of the trial drug.
Who may not be able to join:
- You have brain or spinal cord tumors that have not been treated or are currently active, or you have had or currently have cancer that has spread to the lining around the brain or spinal cord.
- You have fluid build-up around the lungs, heart, or abdomen that is causing symptoms and cannot be controlled with treatment.
- You have a history of lung inflammation or scarring of the lung tissue, or lung inflammation that requires steroid medication.
- You have high blood pressure that cannot be controlled with medication.
- You have serious or poorly controlled heart or blood vessel problems.
- You have had a serious infection in the month before starting the trial.
- You have a weakened immune system, have tested positive for HIV, have any other immune deficiency condition (inherited or acquired), or have had an organ transplant.
- You have other conditions or circumstances — such as alcohol or drug misuse, serious mental illness, or other major health issues — that could affect the study results or your ability to safely participate (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dose limited toxicity (DLT); Recommended phase II dose (RP2D); Objective response rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.